Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
startups
acetylon pharmaceuticals
ambys medicines
boston blog main
boston top stories
cell therapy
constellation pharmaceuticals
deals
ec healthtech
ec investor survey
gene therapy
genentech
holger willenbring
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
mental health
national blog main
national top stories
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
psychedelics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
takeda
third rock ventures
ucsf
university of illinois urbana-champaign
What
future
2
×
medicines
2
×
aiming
ambys
anna
big
biotech
colorful
come
control
deadly
deal
debuted
depends
difficult
diseases
far
formed
heim
industry
investors
launch
liver
look
make
months
new
originally
past
predict
psychedelic
psychedelics
published
startup
startups
takeda
techcrunch
today
treatments
unusual
Language
unset
Current search:
future
×
biotech
×
medicines
×
@techcrunch.com
1 year ago
11 investors predict a colorful, if difficult, future for psychedelic startups
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
